|Venture Round, 2/2011 |
NVM Private Equity
Beringea Private Equity
Altacor develops and brings to market specialist ophthalmic products designed for the needs of both ophthalmologists and patients.
From its headquarters in Cambridge UK, Altacor brings together skills in drug development with in-depth market knowledge and an understanding of the European regulatory environment, to create a portfolio of high quality, differentiated prescription medicines that set new standards in the sector.
Altacor’s pipeline includes products for dry-eye, glaucoma, glaucoma surgery and ocular surgery.